Corrigendum to “Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations”, [Biomed. Pharmacother. 196 (2026) 119020]

Biomedicine & Pharmacotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles